64 related articles for article (PubMed ID: 12804984)
1. Lack of upregulation of epidermal fatty acid binding protein in dithranol induced irritation.
Kucharekova M; Vissers WH; Schalkwijk JJ; van de Kerkhof PC; van der Valk PG
Eur J Dermatol; 2003; 13(3):254-7. PubMed ID: 12804984
[TBL] [Abstract][Full Text] [Related]
2. Transepidermal water vapour loss is not increased during and following dithranol irritation.
Snater E; Janssen EA; van der Valk PG; van de Kerkhof PC
Br J Dermatol; 1995 Jun; 132(6):908-12. PubMed ID: 7662568
[TBL] [Abstract][Full Text] [Related]
3. Skin-derived antileukoproteinase (SKALP) and epidermal fatty acid-binding protein (E-FABP): two novel markers of the psoriatic phenotype that respond differentially to topical steroid.
Kuijpers AL; Bergers M; Siegenthaler G; Zeeuwen PL; van de Kerkhof PC; Schalkwijk J
Acta Derm Venereol; 1997 Jan; 77(1):14-9. PubMed ID: 9059669
[TBL] [Abstract][Full Text] [Related]
4. Implementation of fatty acid carriers to skin irritation and the epidermal barrier.
Schürer NY
Contact Dermatitis; 2002 Oct; 47(4):199-205. PubMed ID: 12492517
[TBL] [Abstract][Full Text] [Related]
5. Calcium-binding protein S100A7 and epidermal-type fatty acid-binding protein are associated in the cytosol of human keratinocytes.
Hagens G; Masouyé I; Augsburger E; Hotz R; Saurat JH; Siegenthaler G
Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):419-27. PubMed ID: 10191275
[TBL] [Abstract][Full Text] [Related]
6. Irritation and staining by dithranol (anthralin) and related compounds. III. Cumulative irritancy and staining during repeated chamber testing.
Brandt H; Mustakallio KK
Acta Derm Venereol; 1983; 63(3):237-40. PubMed ID: 6192640
[TBL] [Abstract][Full Text] [Related]
7. The response of uninvolved skin of patients with psoriasis to single and repeated applications of dithranol cream: an immunohistochemical assessment.
Swinkels OQ; Prins M; van Vlijmen-Willems IM; Gerritsen MJ; van der Valk PG; van de Kerkhof PC
Skin Pharmacol Appl Skin Physiol; 2002; 15(6):385-92. PubMed ID: 12476012
[TBL] [Abstract][Full Text] [Related]
8. Skin irritation by dithranol cream. A blind study to assess the role of the cream formulation.
Prins M; Swinkels OQ; Kolkman EG; Wuis EW; Hekster YA; van der Valk PG
Acta Derm Venereol; 1998 Jul; 78(4):262-5. PubMed ID: 9689292
[TBL] [Abstract][Full Text] [Related]
9. Analysis on the phenotype of E-FABP-gene knockout mice.
Owada Y; Suzuki I; Noda T; Kondo H
Mol Cell Biochem; 2002 Oct; 239(1-2):83-6. PubMed ID: 12479572
[TBL] [Abstract][Full Text] [Related]
10. Bovine epidermal fatty acid-binding protein: determination of ligand specificity and cellular localization in retina and testis.
Kingma PB; Bok D; Ong DE
Biochemistry; 1998 Mar; 37(10):3250-7. PubMed ID: 9521644
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid induces expression of PA-FABP (psoriasis-associated fatty acid-binding protein) gene in human skin in vivo but not in cultured skin cells.
Larsen FG; Voorhees JJ; Aström A
Exp Dermatol; 1994 Oct; 3(5):212-8. PubMed ID: 7881766
[TBL] [Abstract][Full Text] [Related]
12. Induction and axonal localization of epithelial/epidermal fatty acid-binding protein in retinal ganglion cells are associated with axon development and regeneration.
Allen GW; Liu J; Kirby MA; De León M
J Neurosci Res; 2001 Nov; 66(3):396-405. PubMed ID: 11746357
[TBL] [Abstract][Full Text] [Related]
13. Changes in keratinocyte differentiation following mild irritation by sodium dodecyl sulphate.
Le M; Schalkwijk J; Siegenthaler G; van de Kerkhof PC; Veerkamp JH; van der Valk PG
Arch Dermatol Res; 1996 Oct; 288(11):684-90. PubMed ID: 8931871
[TBL] [Abstract][Full Text] [Related]
14. Solution structure and backbone dynamics of human epidermal-type fatty acid-binding protein (E-FABP).
Gutiérrez-González LH; Ludwig C; Hohoff C; Rademacher M; Hanhoff T; Rüterjans H; Spener F; Lücke C
Biochem J; 2002 Jun; 364(Pt 3):725-37. PubMed ID: 12049637
[TBL] [Abstract][Full Text] [Related]
15. Probable interaction between S100A7 and E-FABP in the cytosol of human keratinocytes from psoriatic scales.
Hagens G; Roulin K; Hotz R; Saurat JH; Hellman U; Siegenthaler G
Mol Cell Biochem; 1999 Feb; 192(1-2):123-8. PubMed ID: 10331666
[TBL] [Abstract][Full Text] [Related]
16. Irritation and staining by dithranol (anthralin) and related compounds. IV. Visual estimation of erythema compared with contact thermometry and laser Doppler flowmetry.
Mustakallio KK; Kolari PJ
Acta Derm Venereol; 1983; 63(6):513-8. PubMed ID: 6198841
[TBL] [Abstract][Full Text] [Related]
17. The response of normal human skin to single and repeated applications of dithranol cream: an immunohistochemical assessment.
Swinkels OQ; Prins M; Birker LW; Gerritsen MJ; van der Valk PG; van de Kerkhof PC
Skin Pharmacol Appl Skin Physiol; 2002; 15(4):262-9. PubMed ID: 12218288
[TBL] [Abstract][Full Text] [Related]
18. Expression of recombinant psoriasis-associated fatty acid binding protein in Escherichia coli: gel electrophoretic characterization, analysis of binding properties and comparison with human serum albumin.
Vorum H; Madsen P; Svendsen I; Cells JE; Honoré B
Electrophoresis; 1998 Jul; 19(10):1793-802. PubMed ID: 9719561
[TBL] [Abstract][Full Text] [Related]
19. Dithranol irritation in psoriasis treatment: a study of 68 inpatients.
Kucharekova M; Lieffers L; van de Kerkhof PC; van der Valk PG
J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):176-9. PubMed ID: 15752286
[TBL] [Abstract][Full Text] [Related]
20. Expression pattern of fatty acid-binding proteins in human normal and cancer prostate cells and tissues.
Das R; Hammamieh R; Neill R; Melhem M; Jett M
Clin Cancer Res; 2001 Jun; 7(6):1706-15. PubMed ID: 11410510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
